Access cutting-edge heart failure treatment through this clinical trial at a research site in Shawnee Mission. Study-provided care at no cost to qualified participants.
Access heart failure specialists in Shawnee Mission at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heart failure treatment provided free
This prospective, multicenter, open-label, randomized comparative effectiveness trial, titled CARVTOP-ICD, evaluates the impact of carvedilol versus metoprolol succinate in patients with heart failure with reduced ejection fraction (HFrEF) and an implantable cardioverter defibrillator (ICD). The study will enroll 2,000 participants across 100 U.S. sites and includes an 18-month feasibility phase with 100 participants from 15 sites. Eligible participants must be currently treated with metoprolol
Sponsor: University of Rochester
Check if you qualify for this heart failure clinical trial in Shawnee Mission, KS
If you're searching for heart failure treatment options in Shawnee Mission, KS, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Shawnee Mission research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart failure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.